2008
DOI: 10.1016/j.jmgm.2007.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the P2 and P3 ligand binding features for Hepatitis C virus NS3 protease using some 3D QSAR techniques

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 47 publications
1
6
0
Order By: Relevance
“…2). 20 our result were supported by Wei et al 31 Hypogen-derived hypothesis generated from a set of HCV NS3 protease inhibitors. Such a reported HypoGen hypothesis consisted of the same five pharmacophore features applied in our hypothesis.…”
Section: Pharmacophore Modeling Study For Test Set (10a-g)supporting
confidence: 80%
“…2). 20 our result were supported by Wei et al 31 Hypogen-derived hypothesis generated from a set of HCV NS3 protease inhibitors. Such a reported HypoGen hypothesis consisted of the same five pharmacophore features applied in our hypothesis.…”
Section: Pharmacophore Modeling Study For Test Set (10a-g)supporting
confidence: 80%
“…The docking results are summarized in protease inhibitors [53]. As shown in figure 2, the hydrophile phosphonic acid group of ligand14a is located in the hydrophobic cavity (brown region) of protease protein, leading to a decrease in the inhibitory effect (absence of hydrophobic interactions).…”
Section: Resultsmentioning
confidence: 99%
“…The NS3 protease has been considered as one of the most attractive targets for anti-HCV therapy because it is essential for viral replication and formation of infectious viral particles. Considerable efforts by different research groups have been directed toward development of HCV NS3 protease inhibitors [96]. For example, Nasser S. M. Ismail and coworkers used computational simulations techniques, such as molecular docking and pharmacophore modeling, to design novel indole-based derivatives as HCV NS3 protease inhibitors ( Fig.…”
Section: Indole Derivatives As Protease Inhibitorsmentioning
confidence: 99%